Patient acceptability and satisfaction with a low-dose solubilized vaginal estradiol softgel capsule, TX-004HR

類似資料

• TX-004HR vaginal estradiol has negligible to very low systemic absorption of estradiol
  著者:: Archer, David F., 等
  出版事項: (2017)
• 17β-estradiol/progesterone in a single, oral, softgel capsule (TX-001HR) significantly increased the number of vasomotor symptom-free days in the REPLENISH trial
  著者:: Kaunitz, Andrew M., 等
  出版事項: (2020)
• Consistency of Effect with a Low-Dose, Estradiol Vaginal Capsule (TX-004HR): Evaluating Improvement in Vaginal Physiology and Moderate-to-Severe Dyspareunia in Subgroups of Postmenopausal Women
  著者:: Constantine, Ginger D., 等
  出版事項: (2017)
• Endometrial safety and bleeding profile of a 17β-estradiol/progesterone oral softgel capsule (TX-001HR)(∗)
  著者:: Mirkin, Sebastian, 等
  出版事項: (2020)
• SAT-238 Predictors Of Vaginal/Uterine Bleeding With Oral TX-001HR (Estradiol and Progesterone) Capsules Taken For Menopausal Vasomotor Symptoms
  著者:: Constantine, Ginger, 等
  出版事項: (2019)